Aquestive Therapeutics is trading at $4.00, down 5.44%, with no clear company-specific announcement explaining the October 29 decline.
- The latest company news was its October 27 notice that it will report Q3 results November 3.
- The broader market was also lower: the Nasdaq fell 1.79%, the S&P 500 0.69%, and the Dow 0.70%. This may have contributed, but no direct connection is established.